Mackenzie Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,919
| Closed | -$337K | – | 1695 |
|
|
2024
Q2 | $337K | Sell |
4,919
-2,407
| -33% | -$165K | ﹤0.01% | 1120 |
|
|
2024
Q1 | $507K | Buy |
7,326
+3,289
| +81% | +$228K | ﹤0.01% | 1018 |
|
|
2023
Q4 | $289K | Buy |
+4,037
| New | +$289K | ﹤0.01% | 1165 |
|
|
2023
Q3 | – | Sell |
-7,589
| Closed | -$475K | – | 1610 |
|
|
2023
Q2 | $475K | Buy |
7,589
+1,946
| +34% | +$122K | ﹤0.01% | 1033 |
|
|
2023
Q1 | $306K | Hold |
5,643
| – | – | ﹤0.01% | 1176 |
|
|
2022
Q4 | $299K | Sell |
5,643
-298
| -5% | -$15.8K | ﹤0.01% | 1091 |
|
|
2022
Q3 | $276K | Sell |
5,941
-50,989
| -90% | -$2.37M | ﹤0.01% | 1122 |
|
|
2022
Q2 | $3.25M | Buy |
56,930
+52,389
| +1,154% | +$2.99M | 0.01% | 618 |
|
|
2022
Q1 | $278K | Buy |
4,541
+700
| +18% | +$42.9K | ﹤0.01% | 1153 |
|
|
2021
Q4 | $201K | Buy |
+3,841
| New | +$201K | ﹤0.01% | 1337 |
|